AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always ...
Barcelona, Spain – 18 April 2023: A novel software tool set to improve the management of elderly atrial fibrillation patients with multiple conditions is being designed by the EU-funded and ...
Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and chest discomfort. Furthermore, these symptoms ...
A novel software tool set to improve the management of elderly atrial fibrillation patients with multiple conditions is being designed by the EU-funded and ESC-coordinated EHRA-PATHS consortium. The ...
Guidelines for the management of atrial fibrillation in different parts of the world are largely in agreement on how to handle the condition, but differences can help shed light on alternate ...
Patients with atrial fibrillation (AF) have an increased risk of negative clinical outcomes. In this review article, physicians from the Chinese Academy of Medical Sciences and Peking Union Medical ...
Experts discuss the persistent clinical and systemic challenges in diagnosing and treating atrial fibrillation, emphasizing the need for earlier identification—especially in high-risk, comorbid ...
Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting ...
In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant ...
Drinking a cup of caffeinated coffee daily led to a significant drop in atrial fibrillation (AF) or flutter in patients with sustained AF compared with those who abstained from coffee and caffeine, ...
A novel software tool set to improve the management of elderly atrial fibrillation patients with multiple conditions is being designed by the EHRA-PATHS consortium. The latest updates on this clinical ...